RE: [NMusers] CrcL or Cr in pediatric model

2009-01-12 Thread Ribbing, Jakob
Pete, Is the drug cleared almost completely thru renal elimination? Otherwise, maybe a slope intercept model for CL as a function of CRCL? TVCL=THETA(X)*(WT/70)**0.75+THETA(Y)*CRCL The intercept is nonrenal CL according to the allometric model and the slope according to CRCL. This

RE: [NMusers] CrcL or Cr in pediatric model

2009-01-12 Thread Ribbing, Jakob
Leonid, I usually prefer multiplicative parameterisation as well, since it is easier to set boundaries (which is not necessary for power models, but for multiplicative-linear models). However, boundaries on the additive covariate models can still be set indirectly, using EXIT statements (not as

RE: [NMusers] CrcL or Cr in pediatric model

2009-01-12 Thread Ribbing, Jakob
Correction, I meant WT 50 and 75 in the example below: 75^0.75/(50^0.75)=1.36 -Original Message- From: Ribbing, Jakob Sent: 13 January 2009 00:50 To: nmusers@globomaxnm.com; 'Leonid Gibiansky'; Bonate, Peter Subject: RE: [NMusers] CrcL or Cr in pediatric model Leonid, I usually prefer

Re: [NMusers] CrcL or Cr in pediatric model

2009-01-12 Thread Nick Holford
Peter, Jakob, Leonid, A practical example of how to deal with collinearity of age and weight over a wide range (premature neonates to young adults) using GFR has been recently reported (Rhodin et al 2008). One way to overcome the somewhat imagined concern about using weight for Clcr and

RE: [NMusers] CrcL or Cr in pediatric model

2009-01-12 Thread Ribbing, Jakob
Thank you for this, Nick. Regarding estimating separate eta for the two CL components I completely agree with you. When I talked about a possible correlation component between renal and non-renal CL that could not be attributed to size, my intention was not to estimate separate random components